Interaction Details

There were no interactions found between Tolvaptan and Body Protective Compound 157. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about combining Tolvaptan and Body Protective Compound 157? Ask Dr. Brian Staiger about it by contacting him directly.

Body Protective Compound 157 Overview

Body Protective Compound 157 BPC 157, also known as body protective compound 157 and Bepecin , is a pentadecapeptide derived from human gastric juice. It has attracted significant interest for its potential therapeutic benefits in addressing various musculoskeletal and soft tissue injuries. This peptide has been shown to expedite the healing of tendons, ligaments, and skeletal muscles in numerous preclinical studies. BPC 157 facilitates cell survival, migration, and proliferation, primarily through the activation of the FAK-paxillin pathway and upregulation of growth hormone receptors. Research has indicated that BPC 157 can significantly enhance the outgrowth of tendon fibroblasts, improve wound closure, and stimulate reepithelialization and collagen deposition in skin injuries. Importantly, it has demonstrated effectiveness in models of both traumatic and systemic injuries, indicating a wide range of potential applications. While promising results have been observed in rodent models, the translation of BPC 157's benefits to human clinical applications is still in the early stages.
See More Information Regarding Body Protective Compound 157

Tolvaptan Overview

  • Tolvaptan (Jynarque) is used to slow the worsening of kidney function in certain patients with autosomal dominant polycystic kidney disease (ADPKD; a certain type of inherited kidney disease). Tolvaptan (Jynarque) is in a class of medications called vasopressin V2 receptor antagonists. It works by increasing the amount of water released from the body as urine and decreases the growth of cysts in the kidneys. Removing fluid from the body and slowing the growth of cysts helps to slow the worsening of kidney function.

  • Tolvaptan is also available as a tablet (Samsca) to treat low blood levels of sodium in people who have heart failure or certain other conditions. This monograph only gives information about tolvaptan tablets (Jynarque) to slow the worsening of kidney function in patients with ADPKD. If you are using this medication to treat low levels of sodium in the blood, read the monograph entitled tolvaptan (low blood sodium).

See More Information Regarding Tolvaptan (kidney disease)

Body Protective Compound 157 - More Interactions

Body Protective Compound 157 interacts with 0 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown No interactions have been reported or no interaction data is currently available.

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.

Ask A Pharmacist About Your Herbal Questions!

Dr. Brian Staiger, PharmD

In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!

Ask A Pharmacist